Market revenue in 2023 | USD 16.4 million |
Market revenue in 2030 | USD 28.1 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Clinical Trial Design and Consultation Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.66% in 2023. Horizon Databook has segmented the Brazil clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
Among Latin American countries, Brazil dominated the market. Brazil is a large country with over 200 million people. It has the largest population in Latin America. Brazil is the sixth largest pharmaceutical country in the world.
The regulatory compliance of clinical trials is ensured by the experienced and qualified workforce in Brazil.
The Ministry of Health in Brazil has supported clinical research in the country by stimulating competitiveness and innovation in the healthcare industry. In Brazil, almost 42% of trials are conducted by academic centers, public institutions, universities, and other independent researchers.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Brazil clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account